PHI with Type 2 diabetes
How does this condition affect your private health insurance?
Type 2 Diabetes is a chronic metabolic disorder characterized by high blood sugar levels. It occurs when the body either doesn't produce enough insulin or doesn't use insulin effectively (insulin resistance). This leads to glucose accumulating in the bloodstream. It often develops gradually, typically in adults, and is strongly linked to lifestyle factors like obesity, physical inactivity, and genetics. Symptoms can be subtle, including increased thirst, frequent urination, fatigue, and blurred vision. Untreated, it can lead to severe complications affecting the heart, kidneys, eyes, and nerves, significantly impacting quality of life and increasing the risk of premature death. Management involves diet, exercise, and medication.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several months to years before diagnosis, as symptoms are often subtle and develop gradually.
Duration of Illness (Lifetime)
Chronic, lifelong condition requiring ongoing management.
Cost of Treatment (Initial)
Moderate (diagnosis, initial medication, lifestyle education, specialist consultations).
Cost of Treatment (Lifetime)
High (daily medications, regular monitoring, specialist visits, potential treatment for complications like kidney disease or cardiovascular issues).
Mortality Rate
Moderate to high over a lifetime, primarily due to associated cardiovascular events, kidney failure, or other severe complications.
Risk of Secondary Damages
High (e.g., diabetic neuropathy, nephropathy, retinopathy, cardiovascular disease, stroke, amputations, foot ulcers).
Probability of Full Recovery
Low (while remission is possible with significant lifestyle changes, especially weight loss, it is not considered a complete cure without any future risk or need for monitoring).
Underlying Disease Risk
High (often co-occurs with obesity, hypertension, dyslipidemia, and metabolic syndrome).